SKI Market

A+| A| A-|

Indian Indices

Sensex

74,360.01 13.84
( 0.02%)

Global Indices

Nasdaq

51,596.42 888.35
(1.75%)

Dow Jones

7,607.58 32.90
(0.43%)

Hang Seng

67,369.16 -1,032.97
(-1.51%)

Nikkei 225

10,347.89 15.59
(0.15%)

Forex

USD-INR

95.24 0.16
(0.17%)

EUR-INR

110.83 0.16
(0.15%)

GBP-INR

128.25 0.32
(0.25%)

JPY-INR

0.60 0.00
(0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

12.84

16458.41

EPS(TTM)

Face Value()

Div & Yield %

71.55

0.54

Back

Universal Starch Chem Allied standalone net profit declines 25.36% in the December 2025 quarter

Feb 11,2026

Net profit of Universal Starch Chem Allied declined 25.36% to Rs 5.24 crore in the quarter ended December 2025 as against Rs 7.02 crore during the previous quarter ended December 2024. Sales declined 8.47% to Rs 117.67 crore in the quarter ended December 2025 as against Rs 128.56 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	117.67	128.56	-8
OPM %	8.31	8.16	-
PBDT	8.31	8.64	-4
PBT	6.45	7.07	-9
NP	5.24	7.02	-25

74,360.01 13.84 ( 0.02%)

51,596.42 888.35 (1.75%)

7,607.58 32.90 (0.43%)

67,369.16 -1,032.97 (-1.51%)

10,347.89 15.59 (0.15%)

95.24 0.16 (0.17%)

110.83 0.16 (0.15%)

128.25 0.32 (0.25%)

0.60 0.00 (0.02%)